BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
UBS
QuintilesIMS
Chubb
Deloitte
Cipla
US Army
Medtronic
Citi

Generated: January 18, 2018

DrugPatentWatch Database Preview

Eszopiclone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for eszopiclone and what is the scope of eszopiclone freedom to operate?

Eszopiclone
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Glenmark Generics, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Orchid Hlthcare, Sun Pharma Global, Teva, West-ward Pharms Int, Wockhardt Ltd, and Sunovion Pharms Inc, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for eszopiclone. Thirty-six suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for eszopiclone

US Patents and Regulatory Information for eszopiclone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-001 Dec 15, 2004 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva ESZOPICLONE eszopiclone TABLET;ORAL 091169-003 May 23, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global ESZOPICLONE eszopiclone TABLET;ORAL 091103-003 Apr 3, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva ESZOPICLONE eszopiclone TABLET;ORAL 091169-001 May 23, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Macleods Pharms Ltd ESZOPICLONE eszopiclone TABLET;ORAL 202929-001 Jan 30, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Orchid Hlthcare ESZOPICLONE eszopiclone TABLET;ORAL 091113-001 Jun 10, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Macleods Pharms Ltd ESZOPICLONE eszopiclone TABLET;ORAL 202929-002 Jan 30, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd ESZOPICLONE eszopiclone TABLET;ORAL 208451-003 Sep 15, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc ESZOPICLONE eszopiclone TABLET;ORAL 091151-003 Mar 26, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Orchid Hlthcare ESZOPICLONE eszopiclone TABLET;ORAL 091113-002 Jun 10, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for eszopiclone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-002 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-003 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-001 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-002 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-003 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-001 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-002 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-001 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-001 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-003 Dec 15, 2004 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cerilliant
Federal Trade Commission
Accenture
Cipla
Deloitte
Teva
Chubb
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot